Analysts Set Drägerwerk AG & Co. KGaA (ETR:DRW3) PT at €84.44

Shares of Drägerwerk AG & Co. KGaA (ETR:DRW3) have received a consensus rating of “Buy” from the six analysts that are currently covering the stock, MarketBeat Ratings reports. One analyst has rated the stock with a hold rating and one has assigned a buy rating to the company. The average 12 month price target among brokers that have updated their coverage on the stock in the last year is €81.24 ($92.32).

Several analysts have recently commented on DRW3 shares. Warburg Research set a €88.70 ($100.80) target price on shares of Drägerwerk AG & Co. KGaA in a report on Wednesday. Kepler Capital Markets set a €71.00 ($80.68) price objective on shares of Drägerwerk AG & Co. KGaA in a report on Wednesday. Finally, Nord/LB set a €72.00 ($81.82) price objective on shares of Drägerwerk AG & Co. KGaA in a report on Thursday.

Shares of DRW3 stock traded down €8.10 ($9.20) on Thursday, hitting €59.40 ($67.50). The stock had a trading volume of 315,370 shares, compared to its average volume of 33,804. The business has a 50 day moving average of €69.50 and a 200 day moving average of €73.49. The stock has a market cap of $603.50 million and a price-to-earnings ratio of 4.97. The company has a debt-to-equity ratio of 17.78, a current ratio of 2.17 and a quick ratio of 1.29. Drägerwerk AG & Co. KGaA has a 12-month low of €60.70 ($68.98) and a 12-month high of €82.70 ($93.98).

About Drägerwerk AG & Co. KGaA

Drägerwerk AG & Co KGaA operates as a medical and safety technology company in Europe, the Americas, Africa, Asia, and Australia. The company develops, produces, and markets system solutions, equipment, and services for acute point of care, including emergency care, perioperative care, critical care, and perinatal care.

Read More: Depreciation

Analyst Recommendations for Drägerwerk AG & Co. KGaA (ETR:DRW3)

Receive News & Ratings for Drägerwerk AG & Co. KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Drägerwerk AG & Co. KGaA and related companies with MarketBeat.com's FREE daily email newsletter.